Abstract 4361230: Pulse Field Ablation Have A Mild Impact on Atrial Fibrillation Ablation Workflow And Organization: A Single High-Volume Center Experience

D Davide Ciliberti (University of Florence, Florence, Italy) A Antonio Di Monaco (Miulli General Hospital, Acquaviva Delle Fonti, Italy) F Federico Quadrini (Miulli General Hospital, Acquaviva Delle Fonti, Italy) F Federica Troisi (Miulli General Hospital, Acquaviva Delle Fonti, Italy) N Nicola Vitulano (Miulli General Hospital, Acquaviva Delle Fonti, Italy) V Vincenzo Caccavo (Miulli General Hospital, Acquaviva Delle Fonti, Italy) G Grigorios Katsouras (F MIULLI HOSPITAL, Bari, Italy) L Luca Sgarra (Miulli General Hospital, Bari, Italy) V Vera Perniciaro (Miulli General Hospital, Acquaviva Delle Fonti, Italy) R Rosa Caruso (Miulli General Hospital, Bari, Italy) C Carlo Di Mario (University of Florence, Florence, Italy) M Massimo Grimaldi (Miulli General Hospital, Acquaviva Delle Fonti, Italy)

Abstract

Introduction and Background: Pulsed field ablation (PFA) is a new non-thermal energy source with a selective effect on myocardial cells that limits damage to other tissues. Because it is more painful, it needs to be performed under general anesthesia or deep sedation. Research Questions: We would assess if PFA compared to radiofrequency ablation (RFA) could have an impact on procedural organization and workflow of atrial fibrillation (AF) ablation, including effects on vagal nervous system. Methods: In this retrospective case-control study we analyzed paroxysmal or persistent AF ablations by pulmonary vein isolation, performed over the last year, 2024, in our high-volume center. The population was divided into two matched samples: PFA group under deep sedation and RFA under light sedation. All procedures were supported by electro-anatomical mapping. We collected all procedural times as primary outcome, then we examined all other procedural data and vagal ganglionated plexi (GPs) involvement. Results and Data: This study included 110 Caucasian patients (mean age 57±11,9, 61,8% males), 55 in PFA (mean age 58,1±8,7, 63,6% males) and 55 RFA group (mean age 55,9±14,3, 60% males). Baseline characteristics of patients are reported in fig.1. Longer post-procedural time (43,9±25,2 vs 19,3±8,3 min; p <0,001) was reported in PFA group. On the contrary, shorter skin to skin times (93,5±28,6 vs 131,9±35,2 min; p <0,001), mapping times (6,27±3,5 vs 13,1±4,1 min; p <0,001) and left atrium dwell times (45,6±8,6 vs 73,7±21,6 min; p <0,001) were evidenced for electroporation. No statistical differences were documented between PFA and RFA about pre-procedural (32±10,9 vs 28,1±6,8 min; p 0,96), ablation (22,2±7,5 vs 22,4±9,1 min; p 0,66) and total procedural times (169,47±34,3 vs 179,4±35,2 min; p 0,05). Interestingly, fluoro-time was shorter in RFA (5,3±2,9 vs 3,3±3,2 min; p <0,001), but fluoro-dose was similar (15,3±17,2 vs 13±13,4 mGy/m 2 ; p 0,56). Complication rate was very low for both. About GPs involvement, heart rate variation before and after procedure was similar between PFA and RFA (fig.1). Interstingly, vagal reflexes were more frequently induced using PFA (67,2% vs 30,1%; p <0,001) and atropine use was more in RFA group (20% vs 65,4%; p <0,001). Conclusions: PFA is efficient, safe and feasible with mild impact on periprocedural workflow and organization of AF ablation using deep sedation. Vagal effects were often induced by PFA without clinical effects as compared to RFA.

Article Details

Journal Circulation
Volume / Issue Vol. 152, Issue Suppl_3
Published November 04, 2025
ISSN 0009-7322
Publisher Lippincott Williams & Wilkins

Journal Info

Circulation

Lippincott Williams & Wilkins

ISSN: 0009-7322 Health Sciences

Authors (12)

D

Davide Ciliberti

University of Florence, Florence, Italy

A

Antonio Di Monaco

Miulli General Hospital, Acquaviva Delle Fonti, Italy

F

Federico Quadrini

Miulli General Hospital, Acquaviva Delle Fonti, Italy

F

Federica Troisi

Miulli General Hospital, Acquaviva Delle Fonti, Italy

N

Nicola Vitulano

Miulli General Hospital, Acquaviva Delle Fonti, Italy

V

Vincenzo Caccavo

Miulli General Hospital, Acquaviva Delle Fonti, Italy

G

Grigorios Katsouras

F MIULLI HOSPITAL, Bari, Italy

L

Luca Sgarra

Miulli General Hospital, Bari, Italy

V

Vera Perniciaro

Miulli General Hospital, Acquaviva Delle Fonti, Italy

R

Rosa Caruso

Miulli General Hospital, Bari, Italy

C

Carlo Di Mario

University of Florence, Florence, Italy

M

Massimo Grimaldi

Miulli General Hospital, Acquaviva Delle Fonti, Italy